Conditions: Ovarian Neoplasms; Fallopian Tube Neoplasms; Peritoneal Neoplasms; Neoplasm Metastasis
Interventions: Drug: Sofetabart Mipitecan; Drug: Paclitaxel; Drug: Topotecan; Drug: Gemcitabine; Drug: Pegylated liposomal doxorubicin (PLD); Drug: MIRV; Drug: Bevacizumab; Drug: Carboplatin
Sponsors: Eli Lilly and Company; GOG Foundation; European Network of Gynaecological Oncological Trial Groups (ENGOT); Asia-Pacific Gynecologic Oncology Trials Group
**RECRUITING NOW**
Source: View full study details on ClinicalTrials.gov
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
